News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Ascletis, Inc. Names Allan Baxter, PhD, Former GlaxoSmithKline (GSK) Global Head of Medicines Development, as Chief Strategy Officer



7/11/2011 9:43:15 AM

RESEARCH TRIANGLE PARK, N.C. & HANGZHOU, China--(BUSINESS WIRE)--Ascletis, Inc., a U.S.-China pharmaceutical company developing important medicines for cancer and infectious diseases, today announced the appointment of Allan Baxter, Ph.D. as Chief Strategy Officer. Dr. Baxter, who has been an advisor to Ascletis since its founding, joins Ascletis following a 30 year career at GlaxoSmithKline (GSK), where he ultimately served as Senior Vice President and Global Head of Medicines Development with accountability for GSK’s late-stage drug development pipeline.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES